1.
Is the Neoadjuvant Docetaxel, Cisplatin and 5-Fluorouracil Regimen Superior to Classic Cisplatin and 5-Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma?. J. Can. Res. Updates [Internet]. 2013 Nov. 28 [cited 2025 Oct. 25];2(4): 297-305. Available from: https://neoplasiaresearch.com/index.php/jcru/article/view/427